An Investigational Drug Study to Lower Non-Cholesterol Sterol Levels Associated With Sitosterolemia (0653-062)(COMPLETED)

NCT00092898 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Lipid Metabolism, Inborn Errors
Heart Disease

Interventions

DRUG: MK0653, ezetimibe
DRUG: Comparator: placebo

Sponsor

Organon and Co